nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Letrozole—Pain—Leflunomide—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Letrozole—Constipation—Leflunomide—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Letrozole—Infection—Lisinopril—systemic scleroderma	0.000911	0.000911	CcSEcCtD
Letrozole—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000908	0.000908	CcSEcCtD
Letrozole—Somnolence—Mycophenolic acid—systemic scleroderma	0.000906	0.000906	CcSEcCtD
Letrozole—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Letrozole—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000897	0.000897	CcSEcCtD
Letrozole—Tachycardia—Lisinopril—systemic scleroderma	0.000895	0.000895	CcSEcCtD
Letrozole—Abdominal pain—Azathioprine—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Letrozole—Body temperature increased—Azathioprine—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Letrozole—Skin disorder—Lisinopril—systemic scleroderma	0.000891	0.000891	CcSEcCtD
Letrozole—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Letrozole—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Letrozole—Diarrhoea—Captopril—systemic scleroderma	0.000886	0.000886	CcSEcCtD
Letrozole—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Letrozole—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Letrozole—Irritability—Methotrexate—systemic scleroderma	0.000884	0.000884	CcSEcCtD
Letrozole—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Letrozole—Feeling abnormal—Leflunomide—systemic scleroderma	0.00088	0.00088	CcSEcCtD
Letrozole—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000879	0.000879	CcSEcCtD
Letrozole—Fatigue—Mycophenolic acid—systemic scleroderma	0.000878	0.000878	CcSEcCtD
Letrozole—Nausea—Mometasone—systemic scleroderma	0.000876	0.000876	CcSEcCtD
Letrozole—Anorexia—Lisinopril—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Letrozole—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000873	0.000873	CcSEcCtD
Letrozole—Weight increased—Prednisone—systemic scleroderma	0.000872	0.000872	CcSEcCtD
Letrozole—Pain—Mycophenolic acid—systemic scleroderma	0.000871	0.000871	CcSEcCtD
Letrozole—Constipation—Mycophenolic acid—systemic scleroderma	0.000871	0.000871	CcSEcCtD
Letrozole—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00087	0.00087	CcSEcCtD
Letrozole—Weight decreased—Prednisone—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Letrozole—Cough—Mycophenolate mofetil—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Letrozole—Dizziness—Captopril—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Letrozole—Depression—Prednisone—systemic scleroderma	0.000852	0.000852	CcSEcCtD
Letrozole—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00085	0.00085	CcSEcCtD
Letrozole—Urticaria—Leflunomide—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Letrozole—Abdominal pain—Leflunomide—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Letrozole—Body temperature increased—Leflunomide—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Letrozole—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Letrozole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Letrozole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Letrozole—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Letrozole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Letrozole—Myocardial infarction—Prednisone—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Letrozole—Breast disorder—Methotrexate—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Letrozole—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000834	0.000834	CcSEcCtD
Letrozole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Letrozole—Insomnia—Lisinopril—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Letrozole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Letrozole—Paraesthesia—Lisinopril—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Letrozole—Vomiting—Captopril—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Letrozole—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00082	0.00082	CcSEcCtD
Letrozole—Dyspnoea—Lisinopril—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Letrozole—Rash—Captopril—systemic scleroderma	0.000817	0.000817	CcSEcCtD
Letrozole—Dermatitis—Captopril—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Letrozole—Somnolence—Lisinopril—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Letrozole—Headache—Captopril—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Letrozole—Dyspepsia—Lisinopril—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Letrozole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000805	0.000805	CcSEcCtD
Letrozole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000805	0.000805	CcSEcCtD
Letrozole—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000804	0.000804	CcSEcCtD
Letrozole—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000804	0.000804	CcSEcCtD
Letrozole—Infection—Mycophenolate mofetil—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Letrozole—Decreased appetite—Lisinopril—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Letrozole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Letrozole—Fatigue—Lisinopril—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Letrozole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Letrozole—Pain—Lisinopril—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Letrozole—Constipation—Lisinopril—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Letrozole—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Letrozole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Letrozole—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Letrozole—Diarrhoea—Azathioprine—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Letrozole—Haemoglobin—Prednisone—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Letrozole—Nausea—Captopril—systemic scleroderma	0.00077	0.00077	CcSEcCtD
Letrozole—Haemorrhage—Prednisone—systemic scleroderma	0.000767	0.000767	CcSEcCtD
Letrozole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000766	0.000766	CcSEcCtD
Letrozole—Asthenia—Leflunomide—systemic scleroderma	0.000766	0.000766	CcSEcCtD
Letrozole—Feeling abnormal—Lisinopril—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Letrozole—Pruritus—Leflunomide—systemic scleroderma	0.000755	0.000755	CcSEcCtD
Letrozole—Connective tissue disorder—Prednisone—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Letrozole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Letrozole—Dizziness—Azathioprine—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Letrozole—Asthenia—Mycophenolic acid—systemic scleroderma	0.000731	0.000731	CcSEcCtD
Letrozole—Diarrhoea—Leflunomide—systemic scleroderma	0.000731	0.000731	CcSEcCtD
Letrozole—Urticaria—Lisinopril—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Letrozole—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Letrozole—Body temperature increased—Lisinopril—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Letrozole—Abdominal pain—Lisinopril—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Letrozole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Letrozole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Letrozole—Vomiting—Azathioprine—systemic scleroderma	0.000719	0.000719	CcSEcCtD
Letrozole—Eye disorder—Prednisone—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Letrozole—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Letrozole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000715	0.000715	CcSEcCtD
Letrozole—Infestation NOS—Methotrexate—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Letrozole—Infestation—Methotrexate—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Letrozole—Rash—Azathioprine—systemic scleroderma	0.000713	0.000713	CcSEcCtD
Letrozole—Dermatitis—Azathioprine—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Letrozole—Depression—Methotrexate—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Letrozole—Flushing—Prednisone—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Letrozole—Headache—Azathioprine—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Letrozole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Letrozole—Dizziness—Leflunomide—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Letrozole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Letrozole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Letrozole—Stomatitis—Methotrexate—systemic scleroderma	0.000696	0.000696	CcSEcCtD
Letrozole—Angiopathy—Prednisone—systemic scleroderma	0.000696	0.000696	CcSEcCtD
Letrozole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Letrozole—Pain—Mycophenolate mofetil—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Letrozole—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Letrozole—Sweating—Methotrexate—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Letrozole—Vomiting—Leflunomide—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Letrozole—Alopecia—Prednisone—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Letrozole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Letrozole—Dizziness—Mycophenolic acid—systemic scleroderma	0.000674	0.000674	CcSEcCtD
Letrozole—Rash—Leflunomide—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Letrozole—Dermatitis—Leflunomide—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Letrozole—Mental disorder—Prednisone—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Letrozole—Nausea—Azathioprine—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Letrozole—Headache—Leflunomide—systemic scleroderma	0.000669	0.000669	CcSEcCtD
Letrozole—Malnutrition—Prednisone—systemic scleroderma	0.000668	0.000668	CcSEcCtD
Letrozole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Letrozole—Asthenia—Lisinopril—systemic scleroderma	0.000658	0.000658	CcSEcCtD
Letrozole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000657	0.000657	CcSEcCtD
Letrozole—Pruritus—Lisinopril—systemic scleroderma	0.000649	0.000649	CcSEcCtD
Letrozole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Letrozole—Haemoglobin—Methotrexate—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Letrozole—Rash—Mycophenolic acid—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Letrozole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Letrozole—Haemorrhage—Methotrexate—systemic scleroderma	0.000641	0.000641	CcSEcCtD
Letrozole—Hepatitis—Methotrexate—systemic scleroderma	0.000641	0.000641	CcSEcCtD
Letrozole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000639	0.000639	CcSEcCtD
Letrozole—Headache—Mycophenolic acid—systemic scleroderma	0.000638	0.000638	CcSEcCtD
Letrozole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Letrozole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Letrozole—Nausea—Leflunomide—systemic scleroderma	0.000634	0.000634	CcSEcCtD
Letrozole—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Letrozole—Vision blurred—Prednisone—systemic scleroderma	0.000629	0.000629	CcSEcCtD
Letrozole—Urethral disorder—Methotrexate—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Letrozole—Diarrhoea—Lisinopril—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Letrozole—Ill-defined disorder—Prednisone—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Letrozole—Angioedema—Prednisone—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Letrozole—Dizziness—Lisinopril—systemic scleroderma	0.000607	0.000607	CcSEcCtD
Letrozole—Erythema multiforme—Methotrexate—systemic scleroderma	0.000606	0.000606	CcSEcCtD
Letrozole—Nausea—Mycophenolic acid—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Letrozole—Malaise—Prednisone—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Letrozole—Vertigo—Prednisone—systemic scleroderma	0.0006	0.0006	CcSEcCtD
Letrozole—Eye disorder—Methotrexate—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Letrozole—Cardiac disorder—Methotrexate—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Letrozole—Vomiting—Lisinopril—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Letrozole—Angiopathy—Methotrexate—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Letrozole—Rash—Lisinopril—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Letrozole—Dermatitis—Lisinopril—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Letrozole—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Letrozole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000577	0.000577	CcSEcCtD
Letrozole—Hypertension—Prednisone—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Letrozole—Headache—Lisinopril—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Letrozole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Letrozole—Arthralgia—Prednisone—systemic scleroderma	0.000568	0.000568	CcSEcCtD
Letrozole—Myalgia—Prednisone—systemic scleroderma	0.000568	0.000568	CcSEcCtD
Letrozole—Anxiety—Prednisone—systemic scleroderma	0.000566	0.000566	CcSEcCtD
Letrozole—Alopecia—Methotrexate—systemic scleroderma	0.000566	0.000566	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000565	0.000565	CcSEcCtD
Letrozole—Discomfort—Prednisone—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Letrozole—Mental disorder—Methotrexate—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Letrozole—Malnutrition—Methotrexate—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Letrozole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00055	CcSEcCtD
Letrozole—Dysgeusia—Methotrexate—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Letrozole—Nausea—Lisinopril—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Letrozole—Anaphylactic shock—Prednisone—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Letrozole—Oedema—Prednisone—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Letrozole—Infection—Prednisone—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Letrozole—Back pain—Methotrexate—systemic scleroderma	0.00054	0.00054	CcSEcCtD
Letrozole—Nervous system disorder—Prednisone—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Letrozole—Tachycardia—Prednisone—systemic scleroderma	0.000532	0.000532	CcSEcCtD
Letrozole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000532	0.000532	CcSEcCtD
Letrozole—Skin disorder—Prednisone—systemic scleroderma	0.000529	0.000529	CcSEcCtD
Letrozole—Hyperhidrosis—Prednisone—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—systemic scleroderma	0.000526	0.000526	CcSEcCtD
Letrozole—Anorexia—Prednisone—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Letrozole—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Letrozole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000511	0.000511	CcSEcCtD
Letrozole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Letrozole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000506	0.000506	CcSEcCtD
Letrozole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Letrozole—Malaise—Methotrexate—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Letrozole—Vertigo—Methotrexate—systemic scleroderma	0.000501	0.000501	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—systemic scleroderma	0.000499	0.000499	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000496	0.000496	CcSEcCtD
Letrozole—Insomnia—Prednisone—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Letrozole—Paraesthesia—Prednisone—systemic scleroderma	0.000489	0.000489	CcSEcCtD
Letrozole—Cough—Methotrexate—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Letrozole—Dyspepsia—Prednisone—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Letrozole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Letrozole—Myalgia—Methotrexate—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Letrozole—Chest pain—Methotrexate—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Letrozole—Decreased appetite—Prednisone—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000472	0.000472	CcSEcCtD
Letrozole—Fatigue—Prednisone—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Letrozole—Discomfort—Methotrexate—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Letrozole—Constipation—Prednisone—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Letrozole—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Letrozole—Infection—Methotrexate—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Letrozole—Feeling abnormal—Prednisone—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Letrozole—Nervous system disorder—Methotrexate—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Letrozole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Letrozole—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Letrozole—Anorexia—Methotrexate—systemic scleroderma	0.000434	0.000434	CcSEcCtD
Letrozole—Urticaria—Prednisone—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Letrozole—Abdominal pain—Prednisone—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Letrozole—Body temperature increased—Prednisone—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Letrozole—Insomnia—Methotrexate—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Letrozole—Paraesthesia—Methotrexate—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Letrozole—Dyspnoea—Methotrexate—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Letrozole—Somnolence—Methotrexate—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Letrozole—Dyspepsia—Methotrexate—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Letrozole—Decreased appetite—Methotrexate—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Letrozole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Letrozole—Fatigue—Methotrexate—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Letrozole—Asthenia—Prednisone—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Letrozole—Pain—Methotrexate—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Letrozole—Pruritus—Prednisone—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Letrozole—Feeling abnormal—Methotrexate—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Letrozole—Diarrhoea—Prednisone—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Letrozole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Letrozole—Urticaria—Methotrexate—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Letrozole—Dizziness—Prednisone—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Letrozole—Abdominal pain—Methotrexate—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Letrozole—Vomiting—Prednisone—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Letrozole—Rash—Prednisone—systemic scleroderma	0.000344	0.000344	CcSEcCtD
Letrozole—Dermatitis—Prednisone—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Letrozole—Headache—Prednisone—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Letrozole—Asthenia—Methotrexate—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Letrozole—Nausea—Prednisone—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Letrozole—Pruritus—Methotrexate—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Letrozole—Diarrhoea—Methotrexate—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Letrozole—Dizziness—Methotrexate—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Letrozole—Vomiting—Methotrexate—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Letrozole—Rash—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Letrozole—Headache—Methotrexate—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Letrozole—Nausea—Methotrexate—systemic scleroderma	0.000271	0.000271	CcSEcCtD
